Gerresheimer (ETR:GXI – Get Rating) received a €86.00 ($93.48) price objective from research analysts at Credit Suisse Group in a research note issued on Wednesday, Borsen Zeitung reports. Credit Suisse Group’s price target indicates a potential upside of 27.69% from the company’s current price.
Other equities research analysts have also issued research reports about the stock. The Goldman Sachs Group set a €110.00 ($119.57) target price on shares of Gerresheimer in a research note on Thursday, April 7th. Deutsche Bank Rese… set a €115.00 ($125.00) price objective on shares of Gerresheimer in a research note on Friday, April 8th. JPMorgan Chase & Co. set a €68.90 ($74.89) price objective on shares of Gerresheimer in a research note on Wednesday. Finally, Deutsche Bank Aktiengesellschaft set a €115.00 ($125.00) price objective on shares of Gerresheimer in a research note on Friday, February 18th.
Shares of Gerresheimer stock traded down €2.60 ($2.83) during trading on Wednesday, reaching €67.35 ($73.21). The company had a trading volume of 120,497 shares, compared to its average volume of 140,925. The company has a market cap of $2.11 billion and a price-to-earnings ratio of 25.24. The firm’s fifty day moving average is €68.21 and its 200-day moving average is €76.27. The company has a debt-to-equity ratio of 113.12, a quick ratio of 0.42 and a current ratio of 0.74. Gerresheimer has a fifty-two week low of €53.45 ($58.10) and a fifty-two week high of €99.40 ($108.04).
Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements.
- OrganiGram’s Turnaround Begins To Blossom
- Three Dividend Stocks With Growth Potential
- Exelon Stock Still Has Extraordinary Upside
- Ross Stores On The Verge Of Major Rally
- Greenbrier Companies Stock has Green in its Future
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.